CASE REPORT
Rare case of Streptococcal enteritis in HIV patient
 
More details
Hide details
1
Department of Internal Medicine, Attikon University Hospital of Athens, Greece
 
 
Submission date: 2019-08-19
 
 
Final revision date: 2020-03-20
 
 
Acceptance date: 2020-05-03
 
 
Publication date: 2020-12-12
 
 
HIV & AIDS Review 2020;19(4):284-288
 
KEYWORDS
TOPICS
ABSTRACT
Only a small number of cases of Streptococcus pneumoniae bacteremia with gastrointestinal tract involvement have been reported in the literature, even in immunocompromised patients.
This case report describes an immunosuppressed forty-year old human immunodeficiency virus (HIV)-positive patient with S. pneumoniae bacteremia presenting as acute enteritis. The patient suffered from fever, severe watery diarrhea, and acute abdomen. Laboratory tests showed elevation of inflammatory markers and acute kidney injury. Stool examination was positive for fecal leucocytes, while radiology studies were indicative of respiratory involvement. The patient was rehydrated and initially treated with IV ciproflocaxin and metronidazole, but after positive blood culture result for S. pneumoniae, the treatment was changed to IV ceftriaxone. The patient responded to the treatment and was discharged on 7th day with oral moxifloxacin prescribed. Ten days after finishing the treatment, there was a lower respiratory tract recurrence with negative blood cultures for S. pneumoniae, which responded to meropenem without another recurrence until today.
In the last 26 years (1993-2019), a few cases have been described, two of which in HIV-positive patients. To our knowledge, this is the first case of concurrent severe S. pneumoniae pneumonia and enteritis without any complaints from the respiratory system in a severely immunosuppressed patient.
 
REFERENCES (36)
1.
Frankel RE, Virata M, Hardalo C, Altice FL, Friedland G. Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin Infect Dis 1996; 23: 577-584.
 
2.
Yin Z, Rice BD, Waight P, et al. Invasive pneumococcal disease among HIV-positive individuals, 2000-2009. AIDS 2012; 26: 87-94.
 
3.
Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory.
 
4.
Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2013; 62: 521-524.
 
5.
Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997; 46(RR-8): 1-24.
 
6.
Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices. Pneumococcal vaccination for cochlear implant candidates and recipients: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2003; 52: 739-740.
 
7.
Gentile JH, Sparo MD, Mercapide ME, Luna CM. Adult bacteremic pneumococcal pneumonia acquired in the community. A prospective study on 101 patients. Medicina (B Aires) 2003; 63: 9-14.
 
8.
Laupland KB, Gregson DB, Zygun DA, Doig CJ, Mortis G, Church DL. Severe bloodstream infections: a population-based assessment. Crit Care Med 2004; 32: 992-997.
 
9.
Talbot TR, Hartert TV, Mitchel E, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 2005; 352: 2082-2090.
 
10.
Hargreaves RM, Lea JR, Griffiths H, et al. Immunological factors and risk of infection in plateau phase myeloma. J Clin Pathol 1995; 48: 260-266.
 
11.
Twomey JJ. Infections complicating multiple myeloma and chronic lymphocytic leukemia. Arch Intern Med 1973; 132: 562-565.
 
12.
Chi RC, Jackson LA, Neuzil KM. Characteristics and outcomes of older adults with community-acquired pneumococcal bacteremia. J Am Geriatr Soc 2006; 54: 115-120.
 
13.
Romney MG, Hull MW, Gustafson R, et al. Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population. Clin Infect Dis 2008; 47: 768-774.
 
14.
Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 2000; 342: 681-689.
 
15.
Lipsky BA, Boyko EJ, Inui TS, Koepsell TD. Risk factors for acquiring pneumococcal infections. Arch Intern Med 1986; 146: 2179-2185.
 
16.
Cruickshank HC, Jefferies JM, Clarke SC. Lifestyle risk factors for invasive pneumococcal disease: a systematic review. BMJ Open 2014; 4: e005224.
 
17.
Kantsø B, Simonsen J, Hoffmann S, Valentiner-Branth P, Petersen AM,.
 
18.
Jess T. Inflammatory bowel disease patients are at increased risk of invasive pneumococcal disease: a nationwide Danish cohort study 1977-2013. Am J Gastroenterol 2015; 110: 1582-1587.
 
19.
Shigayeva A, Rudnick W, Green K, et al.; Toronto Invasive Bacterial Diseases Network. Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs. Clin Infect Dis 2016; 62: 139-147.
 
20.
St Maurice A, Schaffner W, Griffin MR, Halasa N, Grijalva CG. Persistent sex disparities in invasive pneumococcal diseases in the conjugate vaccine era. J Infect Dis 2016; 214: 792-797.
 
21.
Wiese AD, Griffin MR, Schaffner W, et al. Opioid analgesic use and risk for invasive pneumococcal diseases: a nested case-control study. Ann Intern Med 2018; 168: 396-404.
 
22.
Tuomanen EI, Austrian R, Masure HR. Pathogenesis of pneumococcal infection. N Engl J Med 1995; 332: 1280-1284.
 
23.
Ampofo K, Bender J, Sheng X, et al. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics 2008; 122: 229-237.
 
24.
Burgos J, Larrosa MN, Martinez A, et al. Impact of influenza season and environmental factors on the clinical presentation and outcome of invasive pneumococcal disease. Eur J Clin Microbiol Infect Dis 2015; 34: 177-186.
 
25.
Kantsø B, Green N, Goldblatt D, Benfield T. Antibody response is more likely to pneumococcal proteins than to polysaccharide after HIV-associated invasive pneumococcal disease. J Infect Dis 2015; 212: 1093-1099.
 
26.
Clark JA, Keroack MA. Pneumococcal appendicitis in a man with HIV infection. N Engl J Med 1993; 328: 1282.
 
27.
Petti CA, Ignatius Ou SH, Sexton DJ. Acute terminal ileitis associated with pneumococcal bacteremia: case report and review of pneumococcal gastrointestinal diseases. Clin Infect Dis 2002; 34: E50-53.
 
28.
Argemi X, Lefebvre N, Baldeyrou M, Douiri N, Hansmann Y. Streptococcus pneumoniae appendicitis and bacteremia in an immunocompetent adult. Med Mal Infect 2016; 46: 106-107.
 
29.
Caierão J, Cornely AF, Da Cunha GR, Mott M, Zavascki AP, Dias C.
 
30.
Streptococcus pneumoniae appendicitis in an adult patient. Am J Emerg Med 2015; 33: 990.e1-3.
 
31.
Ronnachit A, Ellenberger KA, Gray TJ, et al. Streptococcus pneumoniae causing intra-abdominal and pelvic infection: a case series. Cureus 2017; 9: e1967.
 
32.
Emadi-Koochak H, Tabibian E, Rahimi-Dehgolan S. Abdominal pain as extrapulmonary presentation of pneumonia in an adult: a case report. Acta Medica Iranica 2017; 55: 131-133.
 
33.
Crum-Cianflone NF, Wallace MR. Vaccination in HIV-infected adults. AIDS Patient Care and STDs 2014; 28: 397-410.
 
34.
Harboe ZB, Larsen MV, Ladelund S, et al. Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-.
 
35.
infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users. Clin Infect Dis 2014; 59: 1168-1176.
 
36.
Soman RN, Purandare BD, Rodrigues C, Rajwadkar-More V. Acute enteritis associated with pneumococcal bacteremia. J Assoc Physicians India 2009; 57: 173-174.
 
eISSN:1732-2707
ISSN:1730-1270
Journals System - logo
Scroll to top